Skip to main content
. 2019 Apr 18;10(5):338. doi: 10.1038/s41419-019-1570-9

Table 2.

List of oligonucleotides used as PCR primers

Target Sequences
BRD9 F5′-ATGTTCCATGAAGCCTCCAG-3′ / R5′-AGCTCCTTCTTCACCTTCCC-3′
CDKN1A F5′-TTTCTACCACTCCAAACGCC-3′/ R5′-CGGCCAGGGTATGTACATGAG-3′
MYB F5′-AAGCTACTGCCTGGACGAAC-3′ / R5′-CAGGGAGTTGAGCTGTAGGC-3′
MKI67 F5′-AGGCAAAGAAGACCTGCT-3′ / R5′-GAGAGTTTGCGTGGCCTGTA-3′
PCNA F5′-CTGAGGGCTTCGACACCT-3′ / R5′-GTATCCGCGTTATCTTCG-3′
HPRT F5′-TGAGGATTTGGAAAGGGT-3′ / R5′-CCTCCCATCTCCTCCATC-3′
ACTIN F5′-CTCCTGAGCGCAAGTACT-3′ / R5′-CGTCATACTCCTGCTTGC-3′
MYC F5′-ATTCTCTGCTCTCCTCGACG-3′ / R5′-CTGTGAGGAGGTTTGCTGTG-3′
IRF9 F5′-AGGAGGAAGAGGATGCCATG-3′ / R5′-TGCTGCTCCCAATGTCTGAA-3′
DDIT3 F5′-CTCTGGGAGGTGCTTGTGA-3′ / R5′-AACACTCTTGACCCTGCTTC-3′
SOCS3 F5′-AGACTTCGATTCGGGACCAG-3′ / R5′-GGAAACTTGCTGTGGGTGAC-3′
BCL2 F5′-ACAACATCACAGAGGAAGTAGAC-3′ / R5′-CAATCACGCGGAACACTTGA-3′
TCF7L2 F5′-GCAAAGGTCGTAGCTGAGTG-3′ / R5′-TTCGCTTGCTCTTCTCTGGA-3′
TNFSRF14 F5′-TGTAGTCAAGGTGATCGTCTC-3′ / R5′-GCAGGGCCTCAATGACTGT-3′
STAT1 F5′-GCATGAAATCAAGAGCCTGG-3′ / F5′-GTCTCGTGTTCTCTGTTCTG-3′
IER3 F5′-GAACCGAACCCAGCCAAAAG-3′ / R5′-ACACCCTCTTCAGCCATCAG-3′
SOCS3 promoter (chr17:76,355,927-76,356,482) F5′-GCACACACCTGTAATCCCAC-3′ / R5′-ATGGAGTCTTGCTGTGTTGC-3′
IRF9 promoter (chr11:615,758-616,229) F5′-GCACACACCTGTAATCCCAC-3′ / R5′-ATGGAGTCTTGCTGTGTTGC-3′
CDKN1A enhancer (chr6:36,648,195-36,648,503) F5′-ACCTTGTAAGCCTCAGTCTCC-3′ / R5′-ACGTACACTGCATCACCTCA-3′
IER3 promoter (chr17:40,428,089-40,428,716) F5′-GTTTCACAGTCCCCATGCAG-3′ /R5′-TCTGTGGAGGGGACAAATCA-3′
GRM promoter (chr7:85745583 + 85745689) F5′-CCAGTGCCTTCTTCAATACCATTA-3′ / R5′-TCTTCTACTGTCTGAGAGTTGCCTAAA-3′
ZWIT promoter (chr10:58688620 + 58688733) F5′-AGAACTGGAACCATCCTGTAGAGA-3′ / R5′-CTTGCCTTGGAGTTATTTTCCTAAC-3′
SLITRK1 promoter (chr13:83855843 + 83855948) F5′-GTACGTGGTGTATTCTTCATGTGTG-3′ / R5′-TTGGCTGGGATAACACTTCTATGA-3′